Education
About Us
Working with TipRanks
Follow Us
Lee's Pharmaceutical Holdings Limited (HK:0950)
:0950
RESEARCH TOOLSreports
Total Valuation
Lee's Pharmaceutical Holdings Limited has a market cap or net worth of HK$830.26M. The enterprise value is HK$933.99M.
Market CapHK$830.26M
Enterprise ValueHK$933.99M
Share Statistics
Lee's Pharmaceutical Holdings Limited has 588,835,300 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding588,835,300
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Lee's Pharmaceutical Holdings Limited’s return on equity (ROE) is 0.06 and return on invested capital (ROIC) is 3.95%.
Return on Equity (ROE)0.06
Return on Assets (ROA)0.04
Return on Invested Capital (ROIC)3.95%
Return on Capital Employed (ROCE)0.06
Revenue Per Employee1.37M
Profits Per Employee96.00K
Employee Count1,022
Asset Turnover0.53
Inventory Turnover2.25
Valuation Ratios
The current PE Ratio of Lee's Pharmaceutical Holdings Limited is 8.98. Lee's Pharmaceutical Holdings Limited’s PEG ratio is -0.19.
PE Ratio8.98
PS Ratio0.00
PB Ratio0.50
Price to Fair Value0.51
Price to FCF13.75
Price to Operating Cash Flow3.38
PEG Ratio-0.19
Income Statement
In the last 12 months, Lee's Pharmaceutical Holdings Limited had revenue of 1.40B and earned 93.10M in profits. Earnings per share was 0.16.
Revenue1.40B
Gross Profit753.36M
Operating Income113.14M
Pretax Income98.11M
Net Income93.10M
EBITDA260.87M
Earnings Per Share (EPS)0.16
Cash Flow
In the last 12 months, operating cash flow was 58.98M and capital expenditures -11.53M, giving a free cash flow of 47.45M billion.
Operating Cash Flow58.98M
Free Cash Flow47.45M
Free Cash Flow per Share0.08
Dividends & Yields
Lee's Pharmaceutical Holdings Limited pays an annual dividend of HK$0.025, resulting in a dividend yield of 3.55%
Dividend Per ShareHK$0.025
Dividend Yield3.55%
Payout Ratio28.48%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.48
52-Week Price Change25.89%
50-Day Moving Average1.41
200-Day Moving Average1.30
Relative Strength Index (RSI)45.11
Average Volume (3m)435.17K
Important Dates
Lee's Pharmaceutical Holdings Limited upcoming earnings date is Aug 27, 2025, TBA (Confirmed).
Last Earnings DateMay 28, 2025
Next Earnings DateAug 27, 2025
Ex-Dividend DateMay 28, 2025
Financial Position
Lee's Pharmaceutical Holdings Limited as a current ratio of 1.02, with Debt / Equity ratio of 8.50%
Current Ratio1.02
Quick Ratio0.64
Debt to Market Cap0.26
Net Debt to EBITDA0.04
Interest Coverage Ratio8.19
Taxes
In the past 12 months, Lee's Pharmaceutical Holdings Limited has paid 29.50M in taxes.
Income Tax29.50M
Effective Tax Rate0.30
Enterprise Valuation
Lee's Pharmaceutical Holdings Limited EV to EBITDA ratio is 3.25, with an EV/FCF ratio of 24.57.
EV to Sales0.60
EV to EBITDA3.25
EV to Free Cash Flow24.57
EV to Operating Cash Flow3.50
Balance Sheet
Lee's Pharmaceutical Holdings Limited has HK$216.84M in cash and marketable securities with HK$227.30M in debt, giving a net cash position of HK$10.45M billion.
Cash & Marketable SecuritiesHK$216.84M
Total DebtHK$227.30M
Net CashHK$10.45M
Net Cash Per ShareHK$0.02
Tangible Book Value Per ShareHK$0.70
Margins
Gross margin is 62.50%, with operating margin of 8.08%, and net profit margin of 6.65%.
Gross Margin62.50%
Operating Margin8.08%
Pretax Margin7.01%
Net Profit Margin6.65%
EBITDA Margin18.63%
EBIT Margin8.00%
Analyst Forecast
The average price target for Lee's Pharmaceutical Holdings Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast32.95%
EPS Growth Forecast456.69%